Clinical TrialID 29
Ginkgo Biloba Extract in the Treatment of Schizophrenia
NCT05258123
Schizophrenia
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 29
- Evidence Id
- 29
- Core Evidence Id
- 29
- Source Clinical Trial Id
- 24
- Herb2 Clinical Trial Id
- HBCT000024
- Nct Id
- NCT05258123
- Title
- Ginkgo Biloba Extract in the Treatment of Schizophrenia
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Schizophrenia
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Ginkgo Biloba Extract|DRUG: Placebo oral tablet
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 100
- Outcome Measure
- clinical symptoms, symptoms assessed on PANSS, 12 weeks|cognitive functioning, cognitive functioning assessed on RBANS, 12 weeks
- Sponsor Collaborator
- Beijing HuiLongGuan Hospital
- Funded By
- OTHER
- Location
- Beijing HuiLongGuan Hospital, Beijing, 100096, China
- Other Id
- CASPsy4
- Start Date
- 2017-05-15
- Primary Completion Date
- 2018-06-12
- Completion Date
- 2018-08-15
- First Posted
- 2022-02-28
- Results First Posted
- Last Update Posted
- 2022-02-28
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05258123
- Title Cn
- Title En
- Ginkgo Biloba Extract in the Treatment of Schizophrenia
- Bilingual Status
- semi_complete